INTRODUCTION
Pseudohypoparathyroidism (PHP)' is an uncommon metabolic disorder characterized by the biochemical features of hypoparathyroidism (hypocalcemia and hyperphosphatemia), despite apparently normal parathyroid hormone (PTH) secretion, and resistance of the target organs, bone and kidney, to PTH (1) (2) (3) . The biologic action of PTH is mediated by 3',5'-cyclic AMP (cAMP), and patients with PHP Type I exhibit a markedly blunted nephrogenous cAMP response to intravenous infusion of PTH in comparison with normal individuals and patients with other forms of hypoparathyroidism (4) . This observation suggested that PHP Type I (as distinguished from PHP Type II, in which patients are characterized by an absent phosphaturic response to PTH despite a normal urinary cAMP response) is caused by a biochemical defect proximal to cAMP generation, i.e., in the plasma-membrane bound hormone-receptor adenylate cyclase complex. An integral component of the adenylate cyclase complex is the guanine nucleotide regulatory unit (G unit), a protein that couples hormone receptors to the catalytic unit of the enzyme. Recently, it has been found in this and other laboratories that many patients with PHP Type I show a reduced complement of G units in membranes prepared from erythrocytes (5, 6) . Deficient erythrocyte membrane G-unit activity in erythrocyte membranes is associated with decreased responsiveness of diverse tissues (e.g., kidney, thyroid, gonad, and liver) to hormones (e.g., PTH, TSH, gonadotropin, and glucagon) acting via cAMP; patients with normal erythrocyte membrane G-unit activity generally manifest hormone resistance limited to PTH target tissues (7) .
Because human erythrocyte membranes do not contain a hormone-sensitive adenylate cyclase, one cannot I Abbreviations used in this paper: G unit, guanine nucleotide regulatory unit; GTP-'y-S, guanosine 5'-O-(3-thiotriphosphate); IMEM, improved modified Eagle's medium; PGE,, prostaglandin El; PHP, pseudohypoparathyroidism; PTH, parathyroid hormone. test for abnormalities in hormone response in this cell. Hormone receptors and adenylate cyclase have been found, however, in human diploid fibroblasts. We thus chose to study cultured fibroblasts from five patients with PHP Type I and from 11 normal subjects in order to examine the functional consequences of G-unit deficiency. We report here detailed biochemical studies of cultured fibroblasts, which include measurement of G-unit activity, membrane adenylate cyclase activity, and cellular cAMP accumulation. We found decreased G-unit activity in fibroblast membranes from patients manifesting PHP and reduced erythrocyte membrane G-unit activity. We further found reduced synthesis of cAMP with intact fibroblasts, as well as fibroblast plasma membranes. These observations provide strong support for the hypothesis that a deficiency of G units is the cause of impaired hormone-responsive adenylate cyclase activity in vivo.
METHODS
Patients. Five female patients were studied; four were siblings from a large kindred and the fifth was unrelated. The diagnosis of PHP Type I was confirmed by documenting a markedly blunted urinary cAMP response to a standard intravenous infusion of PTH (4). Characteristic features of Albright's hereditary osteodystrophy were present in all patients, including obesity, brachydactyly, subcutaneous ossifications, and short stature in each. These five patients had been previously shown to have deficient (-50% of control) G-unit activity in their erythrocytes and resistance to multiple hormones (i.e., PTH, TSH, and glucagon) with actions mediated by cAMP (5, 8) . The control group comprised five males and six females. All fibroblast strains were not used in all experiments.
Cell culture. Skin specimens from each subject were obtained by 4-mm punch biopsy in the deltoid region, and fibroblast cultures were established by explanation of minced skin fragments. Informed consent was obtained from patients and volunteers for this procedure. At the time of skin biopsy, all PHP Type I patients were receiving vitamin D and thyroid hormone replacement. The ages of the patients (17-28 yr) were comparable to the control group (20-25 yr) . Cells were grown in Improved Modified Eagles Medium (IMEM) supplemented with 10% fetal calf serum, 10-M crystalline zinc insulin, penicillin (100 U/ml), and streptomycin (100 ug/ml) at 37°C in a humidified atmosphere of 5% CO2/95% air. Confluent monolayers of fibroblasts were harvested for passage by trypsinization and subcultured 1:3. Cells were periodically examined for the presence of mycoplasma contamination (9) , and the cell lines used in all experiments were maintained for less than 20 passages in culture.
Intact cell studies. Cell cultures from PHP patients and normal subjects were used at passages 6 through 10. Confluent cell monolayers were dispersed with trypsin and seeded onto 24-well plates (16- (12) .
Preparation of fibroblast membranes. Plasma membrane-enriched fractions were prepared by a modification of the hypotonic lysis method of Kartner et al. (13) (14) . Fibroblast extracts alone did not show measurable adenylate cyclase activity in response to stimulators, and the slight intrinsic activity of CYC-membranes in response to isoproterenol/guanosine 5'-O-(3-thiotriphosphate (GTP--y-S) or NaF ('1.0-1.5 pmol cAMP/tube) was subtracted from the activity of combined fibroblast extract and CYC-membranes to obtain the increment due to addition of fibroblast G units (G-unit activity).
Cholera toxin-dependent [32P]ADP-ribosylation. Fibroblast membranes (32 Mg protein) were incubated for 20 min at 30°C in 100 mM potassium phosphate (pH 7.5), containing 0.1 mM guanosine triphosphate (GTP), 25 MM [32PJNAD (5) (6) (7) (8) (9) (10) Ci/mmol), 20 mM thymidine, 100 U/ml Trasylol, and either cholera toxin (100 Mg/ml; preactivated during a 10-min 30°C incubation in 20 mM dithiothreitol) or an equivalent volume of 20 mM dithiothreitol without cholera toxin (final dithiothreitol concentration in cholera toxin labeling mix was 2 mM). The reaction was terminated by diluting the membrane suspension with 10 vol of ice-cold 100 mM potassium phosphate (pH 7.5), centrifuging (30, (Fig. 1 A) or isoproterenol-GTP-'y-S (Fig. 1 B) . The G-unit activity extracted from PHP samples was clearly reduced at any concentration tested and with either activator system (Fig.  1, A and B) . G-unit activity from control fibroblast membranes was 53.6±9.5 and 27.0±5.3 pmol cAMP/tube, whereas G-unit activity in the PHP group was 22.3±2.6 and 15.2±2.6 pmol cAMP/tube, for NaF-and isoproterenol-GTP-'y-S-stimulated activity with 10 ul of extract added per tube, respectively (mean±SD). These differences between control and PHP fibroblast G-unit activity were highly significant (P < 0.001).
The results of fibroblast G-unit measurement as determined by membrane [32P]ADP-ribose incorporation are presented in Fig. 2 should result in reduced synthesis of cAMP, we compared the effect of multiple stimulators of adenylate cyclase in cultured fibroblast membranes from four PHP patients and five control subjects (Table I) . We found highly significant differences in the adenylate cyclase activity of membranes prepared from PHP fibroblasts as compared with normal. Guanine nucleotides (GTP or its nonhydrolyzable analog GTP-,y-S) and NaF stimulate catalytic activity by interacting directly with the G unit, independent of any requirement for hormone receptor occupancy. The control membranes showed greater adenylate cyclase activation than PHP membranes when either GTP or GTP-,y-S was present in the assay mix (Table  I) . Moreover, the response to the nonphysiologic stimulator NaF was also significantly greater in control membranes than in PHP membranes, emphasizing further a G-unit deficiency as the cause of impaired membrane adenylate cyclase activity.
PGE1 stimulates adenylate cyclase activity in fibroblast membranes by interacting with a membranebound receptor. Occupancy of this receptor by PGE, increases G-unit-mediated catalytic activity (7) . PGE1 stimulation of adenylate cyclase activity in cultured fibroblast membranes was almost totally dependent upon the addition of exogenous guanine nucleotides to the reaction media. We found that PGEI-stimulated adenylate cyclase activity was significantly greater in control membranes than in PHP membranes, whether or not GTP or its nonhydrolyzable analog GTP-'y-S was added (Table I) . 'Concentrations: GTP, GTP-y-S (100 AM), PGE5 (10 AM), NaF (10 mM), forskolin (10 AM).
I P < 0.05, different from control. § P < 0.001, different from control. P < 0.01, different from control.
Decreased adenylate cyclase activity in cultured fibroblast membranes from PHP patients in response to PGEI, guanine nucleotides, and NaF could be due to decreased membrane catalytic activity. We therefore examined the response of cultured fibroblast membranes to forskolin, a diterpene activator of adenylate cyclase whose effects are considered to be due to direct stimulation of the catalytic moiety (20) . The response of adenylate cyclase to forskolin did not differ among control and PHP membranes (Table I) .
We also examined the apparent affinity of the adenylate cyclase complex for GTP-y-S and the activation time of the enzyme with GTP-'y-S in cultured fibroblast membranes from control subjects and patients with PHP. Fig. 3 shows the results of an experiment comparing the adenylate cyclase activity of membranes from four patients with PHP with membranes from five control subjects. Adenylate cyclase activity of the membranes from patients with PHP was lower than that of control membranes for all concentrations of GTP-y-S tested, but there was no difference in affinity detected (apparent Km for GTP-y-S was 5 X 10-8 M for both groups).
We analyzed the rate of enzyme activation by GTP--y-S in cultured fibroblast membranes from four patients with PHP and five control subjects (Fig. 4) . Adenylate cyclase activity in membranes from both groups was linear with respect to time, but the activity of PHP membranes was significantly less than that of normal membranes at each time point. cAMP accumulation in response to PGE, was rapid and, in the presence of the phosphodiesterase inhibitor isobutyl methyl xanthine, reached a plateau at 15 min and then remained stable beyond 60 min (data not shown). We therefore elected to study confluent monolayers 48 h after plating and to incubate cells for 10 min. Two submaximal concentrations of PGE, (0.5 X 10-6 M and 0.5 X 10-5 M) were selected to enhance potential differences in cellular cAMP synthesis and to avoid hormone refractoriness or desensitization.
Cells derived from PHP patients accumulated significantly less cAMP than cells from normal individuals when challenged with PGE, (Fig. 5 , Table II (21) and renal cortex of one patient (22 (24) . These effects could obscure potential differences in membrane adenylate cyclase between PHP and control groups and may account for the large interstrain variability noted by Bourne et al. (23) . Since many factors can modify cyclic nucleotide metabolism in cultured cells, it is difficult to compare directly our study with that of Bourne et al. (23) . Culture conditions such as passage number (25) , cell density (26), time after subculture (27) , serum concentration (28) , and agonist used have been shown to influence significantly the response of the cAMP system.
With human fibroblasts in particular, response to ,B-adrenergic agonists is nonuniform, and cell content of cAMP varies with the cell cycle, the exponential growth phase showing higher cAMP content than cells at confluence (25) . Moreover, the hormone responsiveness of cAMP accumulation by human diploid fibroblasts has been shown to vary with time after division (25, 27) . We therefore carefully standardized our incubation conditions, synchronized cell growth to minimize artifactual influences of the cell cycle, and used PGE1, which has given more uniform responses (29) (30) (31) to stimulate cAMP production in order to avoid variations that might preclude detection of statistically significant differences between cell lines.
The observation that cultured fibroblast membranes and erythrocyte membranes from patients with PHP Type I show a comparable reduction in G-unit complement further supports the genetic basis of this lesion. The growth of diploid fibroblasts from these patients in long-term culture did not interfere with the ultimate expression of the altered adenylate cyclase genotype. These patients represent a syndrome of hormone resistance generalized to diverse tissues (i.e., kidney, thyroid, gonad, liver) that can be explained by a defective adenylate cyclase component common to all these tissues. This component is the G unit, and it is apparent from our current results that a deficiency of G units can impair the ability of an intact cell to accumulate cAMP in response to hormone stimulation and can impair adenylate cyclase activation of membranes by agents acting via the G unit. A similar conclusion can be drawn from data recently reported by Motulsky et al. (32) . Although Bourne et al. (23) were unable to see a significant difference in cAMP response to PGE1 in intact fibroblasts derived from control subjects vs. patients with PHP, the same investigators (32) found deficient G-unit activity in platelet membranes as well as reduced cAMP response to prostacyclin in intact platelets from patients with PHP.
We know of no evidence to suggest that fibroblasts of PHP type I patients function abnormally in vivo. It is therefore not readily apparent what the functional consequence of an impaired cAMP system in these cells may be. However, the cultured fibroblast can provide the model system in which the specific molecular defect responsible for deficient G-unit activity may be elucidated. Furthermore, studies in cultured fibroblasts may lead to further appreciation of the stoichiometry and functional interactions of the multiple adenylate cyclase components, and may enable greater understanding of adenylate cyclase per se. It is entirely conceivable that other PHP genotypes with normal Gunit activity but resistance to multiple hormones will be identified with defects in other components of the cAMP system, e.g., the catalytic unit or phosphodiesterase. As yet, we have not had the opportunity to study cultured fibroblasts from patients with normal G-unit activity.
Finally, our studies with cultured fibroblasts suggest that expression of the genetic defect in PHP Type I may be anticipated in cells from amniotic fluid. If this can be demonstrated, prenatal diagnosis of low G-unit PHP can be achieved, and genetic counseling will become possible.
